MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
*Portfolio Companies: US Venture
Vical (NASDAQ:VICL)
Organization & Developments: Vical
Parents
Vical (NASDAQ:VICL)
Children
2016: Vical's CMV vaccine candidate flunks mid-stage study; shares off 22% premarket - Vical Incorporated (NASDAQ:VICL)
2018: Counting its remaining cash, Vical axes 40 staffers and circles wagons around two Phase II assets – Endpoints News
2018: Vical says another one of its vaccines has crashed and burned in PhII – Endpoints News
2019: Vical stops antifungal trial, lays off staff to eke out cash
DNA-based pharmaceuticals for human disease
VL-2397 is an anti-fungal compound the company in-licensed from Astellas with Vical completing this deal with stock and $250,000 in cash.
Jumps
Finance & Acquisition: Vical
Key people: Vical